Vigilance and surveillance (V&S) is important for optimising MPHO, from donation to clinical application and follow-up care of patients; it includes alertness to the risks and systematic management of undesirable outcomes in donors and recipients. V&S is a safeguard for donors, patients, health professionals and health authorities. The introduction of V&S systems can facilitate the monitoring of adverse occurrences outcomes lead to preventive and corrective measures and an overall improvement in safety, as demonstrated by the impact of haemovigilance on transfusion services, donor care and donor safety.
